Aytu BioPharma Inc (LTS:0A8M)
$ 1.59 -0.01 (-0.62%) Market Cap: 9.90 Mil Enterprise Value: 6.35 Mil PE Ratio: 0 PB Ratio: 0.33 GF Score: 40/100

Q1 2023 Aytu Biopharma Inc Earnings Call Transcript

Nov 14, 2022 / 09:30PM GMT
Release Date Price: $4.09 (+15.32%)
Operator

Good afternoon, ladies and gentlemen, and welcome to the Aytu Biopharma Fiscal 2023 Q1 Results Call. (Operator Instructions) It is now my pleasure to turn the floor over to your host, Roger Weiss. Sir, the floor is yours.

Roger Weiss;Lytham Partners;Vice President
LLC

Thank you very much. Good afternoon everyone and thank you for joining us for Aytu Biopharma's First Quarter Fiscal Year 2023 Financial Results Conference Call. Joining us on today's call is Aytu's CEO, Josh Disbrow; and this company's Chief Financial Officer, Mark Oki.

At the conclusion of today's prepared remarks, we'll open the call for a question-and-answer session. I'd like to remind everyone that today's call is being recorded. A replay of today's call will be available by using the telephone numbers and conference ID provided in the earnings press release issued earlier today. Finally, I'd also like to call to your attention the customary safe harbor disclosure regarding future-looking information. The conference call today will contain certain

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot